2020's IPO par­ty con­tin­ues with four new Nas­daq en­trants, in­clud­ing Cov­il­lion­aire Carl Hansen's Ab­Cellera

Three more com­pa­nies are mak­ing their Wall Street de­buts Fri­day as the in­dus­try’s record-break­ing IPO year nears a con­clu­sion, with two mas­sive rais­es in the group — in­clud­ing the newest Cov­il­lion­aire’s out­fit.

The biotechs Ab­Cellera, 4D Mol­e­c­u­lar Ther­a­peu­tics and Nanobi­otix, as well as biosim­u­la­tion com­pa­ny Cer­tara, all priced late Thurs­day. Cer­tara raised the most of the bunch at a whop­ping $668 mil­lion, while Carl Hansen’s Ab­Cellera neared the half-bil­lion mark at $483 mil­lion. 4DMT raised $193.2 mil­lion in its sec­ond IPO go-around, and Nanobi­otix fol­lowed up with a $99 mil­lion raise of their own.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER